Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease
Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease
clinical studies
Global Medical Institutes (GMI) is an Investigative Research Company which conducts Phase I-IV human clinical trials for the pharmaceutical, biotechnology and medical devices industry through our network of wholly-owned and affiliated clinical research facilities.
GLOBAL MEDICAL INSTITUTES
CORPORATE OFFICE:
Woodlands Professional Buildings
256 Bunn Drive, Suite 6 Princeton, NJ 08540
OFFICE HOURS:
Mon-Fri: 9:00 AM – 5:30 PM
Sat-Sun: Closed
CONTACT INFO:
Phone: (609) 921-6050
Copyright © 2023 Global Medical Institutes
Privacy Policy | Terms of Service | Disclaimer